536747-87-2 Usage
Uses
Used in Pharmaceutical Industry:
(R)-1-Boc-4,4-difluoropyrrolidine-2-carboxylic acid is used as a building block for the preparation of various pharmaceutical compounds. Its chiral (R) configuration allows for the synthesis of enantiopure compounds with specific biological activity, which is crucial for the development of new drugs with targeted therapeutic effects.
Used in Agrochemical Industry:
In the agrochemical industry, (R)-1-Boc-4,4-difluoropyrrolidine-2-carboxylic acid serves as a key intermediate for the synthesis of crop protection products. Its unique structure and functional groups contribute to the development of innovative agrochemicals with enhanced efficacy and selectivity.
Used in Organic Synthesis:
(R)-1-Boc-4,4-difluoropyrrolidine-2-carboxylic acid is utilized as a versatile building block in organic synthesis. Its Boc protecting group and fluorine atoms at the 4th position enable the synthesis of a wide range of organic compounds with diverse applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 536747-87-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,3,6,7,4 and 7 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 536747-87:
(8*5)+(7*3)+(6*6)+(5*7)+(4*4)+(3*7)+(2*8)+(1*7)=192
192 % 10 = 2
So 536747-87-2 is a valid CAS Registry Number.
536747-87-2Relevant articles and documents
PHENOXYETHYL CYCLIC AMINE DERIVATIVES AND THEIR ACTIVITY AS EP4 RECEPTOR MODULATORS
-
Page/Page column 23; 24, (2015/07/07)
The present invention provides a compound of the Formula (I): wherein X, R, R1,R2,R3, R4,R5,R6, R7, R8, and R9 are as defined herein, or a pharmaceutically acceptable salt thereof.
METABOTROPIC GLUTAMATE RECEPTORS 5 MODULATORS AND METHODS OF USE THEREOF
-
, (2012/12/13)
Compounds that modulate GluR5 activity and methods of using the same are disclosed.
OXADIAZOLE COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF
-
Page/Page column 96, (2012/05/05)
The invention provides novel beta-secretase inhibitors and methods for their including methods of treating Alzheimer's disease.
COMPOUNDS CONTAINING FUSED RINGS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF
-
Page/Page column 88, (2011/11/01)
The invention provides novel beta-secretase inhibitors and methods for their use, including methods of treating Alzheimer's disease.